Design, synthesis and spectroscopic properties of crown ether-capped dibenzotetraaza[14]annulenes

  1. Krzysztof M. ZwolińskiORCID Logo and
  2. Julita EilmesORCID Logo

Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Kraków, Poland

  1. Corresponding author email

Associate Editor: H. Ritter
Beilstein J. Org. Chem. 2019, 15, 617–622. doi:10.3762/bjoc.15.57
Received 19 Jun 2018, Accepted 28 Feb 2019, Published 11 Mar 2019


The first crown ether-capped dibenzotetraaza[14]annulenes (DBTAAs), featuring two macrocyclic binding sites fixed in a face-to-face orientation, were synthesized in satisfactory 26–28% isolated yields. Direct N-alkylation of 1,4,10-trioxa-7,13-diazacyclopentadecane by symmetric DBTAA derivatives bearing bromoalkoxy pendants proceed smoothly at a reasonable level of dilution (1.25 mM). The structures were fully characterized by HR-ESIMS, FTIR-ATR, 1H and 13C NMR spectroscopy and elemental analysis.

Keywords: crown ether; dibenzotetraaza[14]annulene; DBTAA; macrocycle; Schiff base


The design and synthesis of novel polycyclic receptor architecture is of fundamental importance, since model recognition studies contribute to much better understanding of complex biological systems [1]. Since the serendipitous discovery of crown ethers by Charles Pedersen in 1967 [2], there have been significant advances in the design and synthesis of sophisticated multidentate macrocycles with mixed-donor sites [3] and high selectivity towards the cationic organic species [4] and ions of certain metal elements [5]. Particulary, synthetic receptors featuring crown ether moieties often equipped with extra side arms bearing pendant functional groups [6,7], have attracted a great deal of interest due to their outstanding binding ability and offer promising applications in catalysis, bioinorganic, biomimetic and analytic chemistry [8]. Polycyclic architecture that incorporate crown ether moieties feature, confined space capable of displaying fascinating properties, different from those observed in bulk solution [9]. Therefore, the design and synthesis of functionalized, cage-like architecture containing converging binding sites arranged along the concave inner surface is in high demand [10]. Nevertheless, synthetic access to such a sophisticated polycyclic architecture is somewhat challenging and often requires the use of special techniques and apparatuses [11]. Particularly, the crown ether-capped (or ‘crown-capped’) porphyrins are synthesized conventionally under high-dilution conditions starting from two porphyrin building blocks bearing complementary functionalities, such as amine and either acyl chloride [12] or halomethyl [13], respectively.

The family of dibenzotetraaza[14]annulenes (abbreviated hereafter as DBTAAs) belong to a class of quadridentate Schiff base macrocycles that display exceptional stability toward light, oxygen and water [14]. Thanks to basic similarities in their structure and physicochemical properties, DBTAAs emerged as non-pyrrolic surrogates of porphyrins, and have become a versatile platform for supramolecular [15], biomimetic [16,17], biological [18,19] and material chemistry [20,21]. Although much effort has been directed towards the study of crown ether-capped porphyrins [22] and sapphyrines [23], little research has been undertaken regarding DBTAAs functionalized with crown ether moieties (see Figure 1).


Figure 1: Timeline for the structure evolution of crown-capped DBTAAs (created on the basis of references [24-28]).

Kruse and Breitmaier [24] reported annulated DBTAA‘s containing benzo-15-crown-5 scaffolds fused with benzenoid rings of the macrocyclic core. Both nickel(II) and cobalt(II) complexes were prepared and their binding properties toward sodium and potassium ions were studied in addition to transition metals. Sakata et al. reported the syntheses and characterization of nickel(II), copper(II) [25] and oxovanadium(IV) [26] complexes of crown ether-annulated DBTAAs, which caused dimerization in the presence of alkali metal and ammonium ions. Sakata et al. reported the synthesis of peripherally functionalized DBTAAs with the two benzo-15-crown-5 scaffolds appended to the meso-benzoyl substituents [27]. Both crown ether-capped macrocycles in a form of free base and nickel(II) and cobalt(II) complexes showed cation and solvent-induced dimerisation. More recently, Raston et al. reported the synthesis of Goedken’s macrocycle tmtaa nickel(II) complex featuring a single oligo(ethylene glycol) chain strapped across the face of the DBTAA macrocyclic core [28]. However, to the best of our knowledge, there are no reports on ‘crown-capped’ dibenzotetraaza[14]annulenes.

Results and Discussion

Design principle and synthesis

To create polycyclic cage architecture, featuring two converging binding sites, capable of simultaneous recognition and cooperative binding of a variety of charged entities [29] or even whole ion pairs within the same superstructure [30], we decided to combine the two macrocyclic building blocks within the same rigidified architecture. Therefore, novel ‘crown-capped’ receptors 3a and 3b were designed to be composed of diaza-crown ether and DBTAA macrocycles. Arrangement of the two macrocyclic components in a face-to-face orientation create a central cavity lined by the two converging binding sites. We decided to make use of the previously reported DBTAA derivatives, bearing 3-bromopropoxy- [31] and 4-bromobutoxybenzoyl [32] pendants, since the presence of rigidifying benzoyl substituents protect the central cavity from collapsing. Simultaneously, the use of short but flexible aliphatic chains as part of the bridges make such receptors flexible enough to adjust the size of the crown cavity to the dimension of the charged entity. The new receptors 3a and 3b contain two apparently differentiated Lewis-basic binding sites, however, from a broader perspective, the nature of the DBTAA binding site can be easily switched into a Lewis-acidic one after appropriate metal insertion (e.g., with zinc(II) ions) [33].

The crown-capped DBTAA’s were synthesized by refluxing 1,4,10-trioxa-7,13-diazacyclopentadecane (1,7-diaza-15-crown-5, kryptofix 21) with the previously reported bromoalkoxy derivatives 2a and 2b in anhydrous acetonitrile containing an excess of triethylamine for 24 hours (Scheme 1). The desired crown ether-capped receptors 3a and 3b were isolated following column chromatography as viscous oils in satisfactory 26–28% isolated yields. The use of either mixtures of acetonitrile and toluene (v:v, varied 4:1 to 1:4) as less polar reaction media did not improve the overall yields despite extension of the reaction time to 48 hours.


Scheme 1: Synthesis of the crown-capped DBTAA receptors 3a and 3b. Reagents and conditions: i) Et3N, CH3CN, reflux, 24 h.

Spectral characterization

The new compounds 3a and 3b have been fully characterized by FTIR-ATR, 1H and 13C NMR spectroscopy, high-resolution electrospray ionization mass spectrometry (HR-ESIMS) and elemental analysis, and the results are in agreement with expected structures (vide infra).

Both the crown ether-capped compounds 3a and 3b are highly symmetrical as was evidenced by both the 1H and 13C NMR spectra. The 13C NMR spectra of 3a and 3b display only one characteristic resonance signal assignable to the carbonyl moieties at δC ≈193 ppm. Simultaneously, macrocyclic inner NH protons gave a well-resolved triplet at δH ≈14.4 ppm arising from the coupling with the olefinic H–C=N protons (J ≈6.7 Hz), observed as doublet at δH ≈8.6 ppm. Nevertheless, the most intriguing feature of the 1H NMR spectra of the crown ether-capped compounds 3a and 3b is the exceptionally large separation of proton resonance signals observed for the crown straps of 3b (Figure 2a). 1H NMR spectra of both the N,N'-dimethyl [34] and N,N'-dibenzyl [35] derivatives of 1,7-diaza-15-crown-5, consist of two multiplets at δH 3.5–3.6 and 2.6–2.9 ppm, corresponding with oxo- and azaethylene proton resonances. Surprisingly, crown ether ethylene proton resonances are pronouncedly shifted downfield for the receptor 3b as compared with the parent 1,7-diaza-15-crown-5 and the receptor 3a. Although exact origin of such a difference needs to be further evaluated, it seems reasonable that the contraction of the bridging chains induces conformational changes that trigger constraints into the benzoyl ring rotation. The fingerprint of the oxoethylene proton resonances is composed of two triplets at δH 3.38 and 3.17 ppm and intense singlet at 3.43 ppm. At the same time, the fingerprint of the azaethylene proton resonances is composed of two triplets at δH 2.53 and 2.45 ppm; the latter is partially overlapped with proton resonances of aliphatic bridges. Receptor 3b displays the properties of chemical shift reagents, similar to the previously reported crown ether-capped porphyrin [36] but of different origin.


Figure 2: 1H NMR spectra (298 K, CDCl3) of: a) crown ether-capped receptor 3b and b) it’s corresponding parent 1,7-diaza-15-crown-5. The insets show an enlarged portion of 1H NMR spectra showing signals attributed to the crown ether ethylene protons.

Since, the macrocyclic dibenzotetraaza[14]annulene core is antiaromatic, and shows no diamagnetic ring current characteristic for porphyrins, the remarkable chemical shift differentiation observed for the crown strap shall be rationalized by its close spatial proximity to anisotropy cones spanning from aromatic substituent’s.

Moreover, vicinal coupling constants 3JH-H found for the crown ethylene bridges fall within the range of 5.4–5.5 Hz, expected for gauche stereochemistry. Such a relaxed crown conformation is suitable for accommodation of large alkali and alkaline-earth cations.

The general features of FTIR-ATR spectra of receptors 3a and 3b are substantially similar to each other and almost undistinguishable from that of the corresponding parent α,ω-dibromoalkoxy-derivatives 2a and 2b. Slightly higher intensities are observed for absorption bands attributed to both the C–H (2924–2857 cm−1) and C–O–C (1246–1044 cm−1) stretching vibrations. The presence of strong absorption bands at ca. 1590 and 1560 cm−1, assignable to the olefinic and imine skeletal stretching modes, implies the macrocyclic scaffold integrity. The FTIR-ATR spectra consist also with the characteristic, but modest in intensity, the absorption band at ca. 1646 cm−1 attributable to the carbonyl moiety stretching vibrations.

The HR-ESIMS (positive ion mode) spectra of crown ether-capped DBTAA‘s 3a and 3b revealed base peaks of the pseudomolecular ions [M + H]+ at m/z 855.4467 and 827.4135, respectively, that are in a very good agreement with the theoretical isotopic distribution patterns.


Creation of polycyclic architectures predisposed to perform higher forms of molecular behaviour is essential for advancing the art of biomimetic chemistry. Therefore, the first crown ether-capped DBTAAs, featuring a face-to-face arrangement of the macrocyclic components, have been synthesized in satisfactory 26–28% isolated yields and fully characterized based on HR-ESIMS, FTIR-ATR, 1H and 13C NMR spectroscopy and elemental analysis. These novel receptors are expected to bind both the transition, alkali and alkaline-earth metals, and also, after DBTAA subunit metalation the whole ion pairs. The binding properties of the crown ether-capped DBTAA receptors are under investigation and will be reported elsewhere.


General procedure for the synthesis of crown ether-capped DBTAA’s 3a and 3b

1,7-Diaza-15-crown-5 (0.1 mmol, 22 mg) together with triethylamine (0.05 mL) was added to a suspension of appropriate α,ω-dibromoalkoxy macrocyclic derivative 2a or 2b (0.1 mmol) in 80 mL of anhydrous acetonitrile and stirred under reflux for 24 h. In due course, the orange precipitate gradually disappeared and a clear red solution was obtained. Afterwards, the reaction mixture was evaporated to dryness under reduced pressure and the crude residue was taken up in 20 mL of chloroform and washed with distilled water (2 × 50 mL). The organic phase was dried over anhydrous MgSO4, filtered through a glass filter, concentrated to a minimal volume and applied directly onto the top of a silicagel column equilibrated with chloroform. The column was firstly eluted isocratically with a mixture of chloroform and acetone (1:1, v/v) to remove any unreacted traces of α,ω-dibromoalkoxy macrocyclic derivatives 2a or 2b. The second band containing undesired site products was eluted isocratically with a mixture of chloroform and methanol (1:1, v/v). The third, main band, was eluted isocratically with a mixture of CHCl3/MeOH/NH3aq (10:10:1, v/v/v), evaporated to dryness under reduced pressure, and kept in a vacuum overnight at ambient temperature to remove all volatiles.

Crown ether-capped DBTAA macrocycle 3a: [7,16-{2,2'-[7,13-bis(3-propyloxy)-1,4,10-trioxa-7,13-diazacyclopentadecane]dibenzoyl}-5,14-dihydrodibenzo[b,i][1,4,8,11]tetraazacyclotetradecine]: Orange oil. Isolated yield 26.1% (26 mg). 1H NMR (300 MHz, CDCl3, TMS, 298 K) δ 1.49 (m, 4H, CH2), 1.68 (m, 4H, CH2), 2.44 (m, 8H, NCH2), 2.53 (t, 3J = 5.4 Hz, 4H, NCH2), 3.17 (t, 3J = 5.5 Hz, 4H, OCH2), 3.38 (t, 3J = 5.4 Hz, 4H, OCH2), 3.43 (s, 4H, OCH2), 4.05 (t, 3J = 5.6 Hz, 4H, CH2), 6.98–7.18 (m, 12H, H-3’,5’,3,4,5,6), 7.35 (dd, 4J = 1.7 Hz, 3J = 7.5 Hz, 2H, H-6’), 7.43 (ddd, 4J = 1.8 Hz, 3J = 7.4 Hz, 3J = 8.4 Hz, 2H, H-4’), 8.59 (d, 3J = 6.4 Hz, 4H, N=C-H), 14.44 (t, 3J = 6.6 Hz, 2H, NH); 13C{1H} NMR (75 MHz, CDCl3, TMS, 298 K) δ 23.68, 27.31, 53.35, 54.89, 56.25, 68.57, 70.03, 70.38, 110.44, 111.92, 115.58, 121.11, 126.49, 129.29, 129.45, 131.18, 137.23, 153.10, 155.55, 192.97 (C=O); FTIR (ATR) ν: 3069 (C=C), 2925 (C-H), 2857 (C-H), 1646 (C=O), 1589 (C=N), 1560 (C=C), 1488, 1446, 1286, 1246 (COC), 1137, 1102, 1044 (COC), 908, 822, 745, 660 cm−1; HR-ESIMS (+νe mode) m/z (%): [M + H]+ calcd for C50H59N6O7, 855.4445; found, 855.4467 (100), Δm = 2.2 ppm; anal. calcd for C50H58N6O7·0.5CHCl3: C, 66.31; H, 6.45; N, 9.19; found: C, 66.16; H, 6.58; N, 9.02.

Crown ether-capped DBTAA macrocycle 3b: [7,16-{2,2'-[7,13-bis(4-butyloxy)-1,4,10-trioxa-7,13-diazacyclopentadecane]dibenzoyl}-5,14-dihydrodibenzo[b,i][1,4,8,11]tetraazacyclotetradecine]: Red oil. Isolated yield 28.7% (16 mg). 1H NMR (300 MHz, CDCl3, TMS, 298 K) δ 1.82 (m, 4H, CH2), 2.53 (m, 12H, NCH2), 3.25 (t, 3J = 5.3 Hz, 4H, OCH2), 3.46 (s, 4H, OCH2), 3.47 (t, 3J = 4.8 Hz, 4H, OCH2), 4.03 (t, 3J = 5.3 Hz, 4H, CH2), 6.97–7.18 (m, 12H, H-3’,5’,3,4,5,6), 7.41–7.47 (m, 4H, H-4’,6’), 8.59 (d, 3J = 6.7 Hz, 4H, N=C-H), 14.44 (t, 3J = 6.7 Hz, 2H, NH); 13C{1H} NMR (75 MHz, CDCl3, TMS, 298 K) δ 26.90, 52.85, 53.87, 54.42, 66.51, 68.43, 70.09, 70.29, 110.56, 111.75, 115.07, 121.33, 126.39, 129.44, 129.83, 131.44, 136.83, 152.52, 155.40, 192.79 (C=O); FTIR (ATR) ν: 3069 (C=C), 2924 (C-H), 2862 (C-H), 1647 (C=O), 1589 (C=N), 1562 (C=C), 1489, 1449, 1287, 1247 (COC), 1139, 1101, 1045 (COC), 908, 823, 742 cm−1; HR-ESIMS (+νe mode) m/z (%): [M + H]+ calcd for C48H55N6O7, 827.4132; found, 827.4135 (100), Δm = 0.3 ppm; anal. calcd for C48H54N6O7.CH2Cl2: C, 64.54; H, 6.19; N, 9.22; found: C, 64.81; H, 6.32; N, 8.85.

Supporting Information

Supporting Information File 1: Detailed descriptions of experimental methods and copies of original FTIR-ATR, HR-ESIMS, 1H and 13C NMR spectra for all new compounds.
Format: PDF Size: 1.3 MB Download


Financial support from the Polish Ministry of Science and Higher Education (Project NN204165236) is gratefully acknowledged.


  1. Lehn, J.-M. Supramolecular Chemistry – Concepts and Perspectives; VCH: Weinheim, Germany, 1995. doi:10.1002/3527607439
    Return to citation in text: [1]
  2. Pedersen, C. J. J. Am. Chem. Soc. 1967, 89, 2495–2496. doi:10.1021/ja00986a052
    Return to citation in text: [1]
  3. Izatt, R. M.; Christensen, J. K., Eds. Synthetic Multidentate Macrocyclic Compounds; Academic Press, Inc.: New York, 1978.
    Return to citation in text: [1]
  4. Späth, A.; König, B. Beilstein J. Org. Chem. 2010, 6, No. 32. doi:10.3762/bjoc.6.32
    Return to citation in text: [1]
  5. Arduini, A.; Casnati, A.; Pochini, A.; Ungaro, R. Curr. Opin. Chem. Biol. 1997, 1, 467–474. doi:10.1016/s1367-5931(97)80040-3
    Return to citation in text: [1]
  6. Stadlbauer, S.; Riechers, A.; Späth, A.; König, B. Chem. – Eur. J. 2008, 14, 2536–2541. doi:10.1002/chem.200701442
    Return to citation in text: [1]
  7. Späth, A.; König, B. Tetrahedron 2010, 66, 1859–1873. doi:10.1016/j.tet.2010.01.028
    Return to citation in text: [1]
  8. Gokel, G. Crown Ethers and Cryptands; Royal Society of Chemistry: Cambridge, U. K., 1991.
    Return to citation in text: [1]
  9. Jiou, J.; Chiravuri, K.; Gudapati, A.; Gassensmith, J. J. Curr. Org. Chem. 2014, 18, 2002–2009. doi:10.2174/1385272819666140514005254
    Return to citation in text: [1]
  10. Kubik, S. Top. Curr. Chem. 2012, 319, 1–34. doi:10.1007/128_2011_244
    Return to citation in text: [1]
  11. Rossa, L.; Vögtle, F. Top. Curr. Chem. 1983, 113, 1–86. doi:10.1007/3-540-12397-0_1
    Return to citation in text: [1]
  12. Collman, J. P.; Zhang, X.; Herrmann, P. C.; Uffelman, E. S.; Boitrel, B.; Straumanis, A.; Brauman, J. I. J. Am. Chem. Soc. 1994, 116, 2681–2682. doi:10.1021/ja00085a083
    Return to citation in text: [1]
  13. Comte, C.; Gros, C. P.; Koeller, S.; Guilard, R.; Nurco, D. J.; Smith, K. M. New J. Chem. 1998, 22, 621–626. doi:10.1039/a709181h
    Return to citation in text: [1]
  14. Mountford, P. Chem. Soc. Rev. 1998, 27, 105–116. doi:10.1039/a827105z
    Return to citation in text: [1]
  15. Pawlica, D.; Marszałek, M.; Mynarczuk, G.; Sieroń, L.; Eilmes, J. New J. Chem. 2004, 28, 1615–1621. doi:10.1039/b409298h
    Return to citation in text: [1]
  16. Paschke, J.; Kirsch, M.; Korth, H.-G.; de Groot, H.; Sustmann, R. J. Am. Chem. Soc. 2001, 123, 11099–11100. doi:10.1021/ja015544v
    Return to citation in text: [1]
  17. Sustmann, R.; Korth, H.-G.; Kobus, D.; Baute, J.; Seiffert, K.-H.; Verheggen, E.; Bill, E.; Kirsch, M.; de Groot, H. Inorg. Chem. 2007, 46, 11416–11430. doi:10.1021/ic700961b
    Return to citation in text: [1]
  18. Bončina, M.; Podlipnik, Č.; Piantanida, I.; Eilmes, J.; Teulade-Fichou, M.-P.; Vesnaver, G.; Lah, J. Nucleic Acids Res. 2015, 43, 10376–10386. doi:10.1093/nar/gkv1167
    Return to citation in text: [1]
  19. Radić-Stojković, M.; Marjanović, M.; Pawlica, D.; Dudek, Ł.; Eilmes, J.; Kralj, M.; Piantanida, I. New J. Chem. 2010, 34, 500–507. doi:10.1039/b9nj00490d
    Return to citation in text: [1]
  20. Grolik, J.; Sieroń, L.; Eilmes, J. Tetrahedron Lett. 2006, 47, 8209–8213. doi:10.1016/j.tetlet.2006.09.134
    Return to citation in text: [1]
  21. Paquette, J. A.; Gilroy, J. B. J. Polym. Sci., Part A: Polym. Chem. 2016, 54, 3257–3266. doi:10.1002/pola.28211
    Return to citation in text: [1]
  22. Even, P.; Boitrel, B. Coord. Chem. Rev. 2006, 250, 519–541. doi:10.1016/j.ccr.2005.09.003
    Return to citation in text: [1]
  23. Sessler, J. L.; Brucker, E. A. Tetrahedron Lett. 1995, 36, 1175–1176. doi:10.1016/0040-4039(94)02490-3
    Return to citation in text: [1]
  24. Kruse, R.; Breitmaier, E. Chem. Ber. 1981, 114, 832–836. doi:10.1002/cber.19811140246
    Return to citation in text: [1] [2]
  25. Sakata, K.; Annoura, T. Inorg. Chim. Acta 1990, 176, 123–129. doi:10.1016/s0020-1693(00)85102-6
    Return to citation in text: [1] [2]
  26. Sakata, K.; Kawano, T.; Annoura, T. Synth. React. Inorg. Met.-Org. Chem. 1994, 24, 905–912. doi:10.1080/00945719408001310
    Return to citation in text: [1] [2]
  27. Sakata, K.; Shimoda, M.; Hashimoto, M. J. Heterocycl. Chem. 1996, 33, 1593–1598. doi:10.1002/jhet.5570330607
    Return to citation in text: [1] [2]
  28. Hardie, M. J.; Malic, N.; Nichols, P. J.; Raston, C. L. Tetrahedron Lett. 2001, 42, 8075–8079. doi:10.1016/s0040-4039(01)01704-x
    Return to citation in text: [1] [2]
  29. Kobuke, Y.; Kokubo, K.; Munakata, M. J. Am. Chem. Soc. 1995, 117, 12751–12758. doi:10.1021/ja00156a012
    Return to citation in text: [1]
  30. Kubik, S.; Goddard, R. J. Org. Chem. 1999, 64, 9475–9486. doi:10.1021/jo991087d
    Return to citation in text: [1]
  31. Dudek, Ł.; Grolik, J.; Kaźmierska, A.; Szneler, E.; Eilmes, A.; Stadnicka, K.; Eilmes, J. Tetrahedron Lett. 2011, 52, 3597–3601. doi:10.1016/j.tetlet.2011.05.008
    Return to citation in text: [1]
  32. Pawlica, D.; Radić-Stojković, M.; Dudek, Ł.; Piantanida, I.; Sieroń, L.; Eilmes, J. Tetrahedron 2009, 65, 3980–3989. doi:10.1016/j.tet.2009.03.030
    Return to citation in text: [1]
  33. Geduhn, J.; Walenzyk, T.; König, B. Curr. Org. Synth. 2007, 4, 390–412. doi:10.2174/157017907782408770
    Return to citation in text: [1]
  34. Solov'ev, V. P.; Strakhova, N. N.; Kazachenko, V. P.; Solotnov, A. F.; Baulin, V. E.; Raevsky, O. A.; Rüdiger, V.; Eblinger, F.; Schneider, H.-J. Eur. J. Org. Chem. 1998, 1379–1389. doi:10.1002/(sici)1099-0690(199807)1998:7<1379::aid-ejoc1379>;2-9
    Return to citation in text: [1]
  35. Gatto, V. J.; Arnold, K. A.; Viscariello, A. M.; Miller, S. R.; Morgan, C. R.; Gokel, G. W. J. Org. Chem. 1986, 51, 5373–5384. doi:10.1021/jo00376a059
    Return to citation in text: [1]
  36. Chang, C. K. J. Am. Chem. Soc. 1977, 99, 2819–2822. doi:10.1021/ja00450a080
    Return to citation in text: [1]

© 2019 Zwoliński and Eilmes; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License ( Please note that the reuse, redistribution and reproduction in particular requires that the authors and source are credited.
The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (

Back to Article List